Evidence map›Paper›PMID 27450559›Full record

ArticleLipids2016

Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Gregory G Martin, Sarah Chung, Danilo Landrock, Kerstin K Landrock, Lawrence J Dangott, Xiaoxue Peng, Martin Kaczocha, Eric J Murphy, Ann B Kier, Friedhelm Schroeder

Open access · greenAbstract read
In one paragraph

Article in Lipids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Hypothalamic endocannabinoids in obesity: an old story with new challenges.Cellular and molecular life sciences : CMLS · 2021
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Gregory G MartinDepartment of Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA.
Sarah ChungDepartment of Pathobiology, Texas A&M University, College Station, TX, 77843-4466, USA.
Danilo LandrockDepartment of Pathobiology, Texas A&M University, College Station, TX, 77843-4466, USA.
Kerstin K LandrockDepartment of Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA.
Lawrence J DangottProtein Chemistry Laboratory, Texas A&M University, College Station, TX, 77843-2128, USA.
Xiaoxue PengDepartment of Anesthesiology, Stony Brook University, Stony Brook, NY, 11794, USA.
Martin KaczochaDepartment of Anesthesiology, Stony Brook University, Stony Brook, NY, 11794, USA.
Eric J MurphyDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, 58202-9037, USA.
Ann B KierDepartment of Pathobiology, Texas A&M University, College Station, TX, 77843-4466, USA.
Friedhelm SchroederDepartment of Physiology and Pharmacology, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA. fschroeder@cvm.tamu.edu.
Texas A&M University · USStony Brook Medicine · USStony Brook University · USUniversity of North Dakota · USWeatherford College · US

Funding

FABPs: Novel Roles in Pain and InflammationR01DA035949 · NIDA · STATE UNIVERSITY NEW YORK STONY BROOK · PI KACZOCHA, MARTIN · 2014 to 2022
$3.0M
Veterinary Student Research TrainingT35OD010991 · OD · TEXAS A&M AGRILIFE RESEARCH · PI GADDY, DANA · 2012 to 2025
$920k
Research Education Program for Laboratory Animal Medicine VeterinariansR25OD016574 · OD · TEXAS A&M UNIVERSITY · PI KIER, ANN B. · 2013 to 2016
$578k
NIDA NIH HHS R01 DA035949NIH HHS R25 OD016574NIH HHS T35 OD010991
6 · The paper itself

Abstract

Although liver fatty acid binding protein (FABP1, L-FABP) is not detectable in the brain, Fabp1 gene ablation (LKO) markedly increases endocannabinoids (EC) in brains of male mice. Since the brain EC system of females differs significantly from that of males, it was important to determine if LKO differently impacted the brain EC system. LKO did not alter brain levels of arachidonic acid (ARA)-containing EC, i.e. arachidonoylethanolamide (AEA) and 2-arachidonoylglycerol (2-AG), but decreased non-ARA-containing N-acylethanolamides (OEA, PEA) and 2-oleoylglycerol (2-OG) that potentiate the actions of AEA and 2-AG. These changes in brain potentiating EC levels were not associated with: (1) a net decrease in levels of brain membrane proteins associated with fatty acid uptake and EC synthesis; (2) a net increase in brain protein levels of cytosolic EC chaperones and enzymes in EC degradation; or (3) increased brain protein levels of EC receptors (CB1, TRVP1). Instead, the reduced or opposite responsiveness of female brain EC levels to loss of FABP1 (LKO) correlated with intrinsically lower FABP1 level in livers of WT females than males. These data show that female mouse brain endocannabinoid levels were unchanged (AEA, 2-AG) or decreased (OEA, PEA, 2-OG) by complete loss of FABP1 (LKO).

Indexed as

AnimalsArachidonic AcidBrainEndocannabinoidsEthanolaminesFatty Acid-Binding ProteinsFemaleGlyceridesMaleMice2-oleoylglycerolArachidonic AcidEndocannabinoidsEthanolaminesFabp1 protein, mouseFatty Acid-Binding ProteinsGlyceridesN-acylethanolaminesBrainEndocannabinoidFABP1FemaleGene ablationMouse

Identifiers

PMID27450559
PMCPMC5418128
OpenAlexW2477207205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.